Tag Archives: Forbes

Feds charge Heritage execs with price fixing; DOJ ringing out 2016 on a roll against Pharma offenses

The former chief executive and former president of generic drug company Heritage Pharmaceuticals Inc. (Eatontown, NJ) have been charged with conspiring to fix prices, the first charges in a continuing… Read more »

Alexion Suddenly Ousts CEO, CFO; what’s really going on?

Alexion Pharmaceuticals Inc. (New Haven CT), maker of one of the world’s most expensive medicines, announced on Monday (December 12, 2106) its CEO and CFO were departing amid an internal… Read more »

US Surgeon General sounds alarm on e-cigarettes, teens; but report shows gross misunderstanding of entire subject

The U.S. surgeon general in a report released on Thursday (December 8, 2016) called for action to reduce the use of e-cigarettes among young people, noting they have overtaken cigarettes… Read more »

Trump picks healthcare “dream team;” or is it something else?

President-elect Donald Trump has assembled his healthcare “dream team.” Rep. Tom Price (R-GA), a longtime critic of the Affordable Care Act but champion of health IT legislation that reduces the burden on physicians,… Read more »

Antitrust Trial for Anthem, Cigna Begins; what to expect with Republicans in charge

Anthem Inc. (Indianapolis IN), Cigna Corp. (Bloomfield CT) and the U.S. government on Monday (November 21, 2016) offered a federal judge very different views of the impact their proposed $48… Read more »

Trump win sends pharma stocks up, while hospitals plunge; fate of Obamacare far from clear

Pharmaceutical stocks and bonds were among the day’s biggest winners Wednesday (November 9, 2016) as the sweeping Republican victory in US elections eased concern that price controls might be imposed… Read more »

Needing cash, Valeant in talks to sell stomach-drug unit in $10 billion deal; hedge-fund icon Bill Ackman finally has a good day

Valeant Pharmaceuticals International Inc. (Laval Quebec) is in advanced talks to sell a big stomach-drug business to Japan’s Takeda Pharmaceutical Co. for about $10 billion, a move seen easing pressure on Valeant over its… Read more »

Aetna tops Wall Street’s 3Q expectations; So just how bad is it out there?

Aetna Inc.’s (Hartford CT) third-quarter earnings rose nearly 8% to top Wall Street forecasts, as growing government business and cost cutting countered higher costs from the health insurer’s Affordable Care… Read more »

Millions choose to pay Obamacare fines rather than enroll; Simple solution–higher fines or…

The architects of the Affordable Care Act thought they had a blunt instrument to force people–even the young and invincible–to buy insurance through the law’s online marketplaces: a tax penalty… Read more »